Cas no 1106-50-9 (Sulfinpyrazone Sulfone)
Sulfinpyrazone Sulfone Chemical and Physical Properties
Names and Identifiers
-
- 3,5-Pyrazolidinedione,1,2-diphenyl-4-[2-(phenylsulfonyl)ethyl]-
- 1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
- 1,2-Diphenyl-4-[2-(phenylsulfonyl)ethyl]-3,5-pyrazolidinedione
- 1,2-diphenyl-4-[2-(phenylsulfonyl)ethyl]pyrazolidine-3,5-dione
- 4-(2-benzenesulfonyl-ethyl)-1,2-diphenyl-pyrazolidine-3,5-dione
- Sulfinpyrazone sulfone
- G 31442
- Sulfinpyrazone impurity A
- 1,2-diphenyl-4-(2-(phenylsulfonyl)ethyl)pyrazolidine-3,5-dione
- 1,2-diphenyl-3,5-dioxo-4-(2'-phenylsulfonylethyl)-pyrazolidine
- 1,2-Diphenyl-4-(2-(phenylsulfonyl)ethyl)-3,5-pyrazolidinedione
- CHEBI:143290
- DTXSID00911788
- 4-[2-(benzenesulfonyl)ethyl]-1,2-diphenylpyrazolidine-3,5-dione
- 5M9FOG2KDI
- SULFINPYRAZONE IMPURITY A [EP IMPURITY]
- NS00045108
- UNII-5M9FOG2KDI
- 3,5-PYRAZOLIDINEDIONE, 1,2-DIPHENYL-4-(2-(PHENYLSULFONYL)ETHYL)-
- 1,2-Diphenyl-4-(2-(phenylsulphonyl)ethyl)pyrazolidine-3,5-dione
- G-31442
- 1106-50-9
- EINECS 214-169-5
- Sulfinpyrazone Sulfone
-
- Inchi: 1S/C23H20N2O4S/c26-22-21(16-17-30(28,29)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2
- InChI Key: DQUYGWDNTAETLI-UHFFFAOYSA-N
- SMILES: S(C1C=CC=CC=1)(CCC1C(N(C2C=CC=CC=2)N(C2C=CC=CC=2)C1=O)=O)(=O)=O
Computed Properties
- Exact Mass: 420.11400
- Monoisotopic Mass: 420.11437830g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 34
- Rotatable Bond Count: 2
- Complexity: 908
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 8
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 6.8
- Topological Polar Surface Area: 83.1?2
Experimental Properties
- PSA: 83.14000
- LogP: 4.67240
Sulfinpyrazone Sulfone Customs Data
- HS CODE:2933990090
- Customs Data:
China Customs Code:
2933990090Overview:
2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Sulfinpyrazone Sulfone Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | S373690-50mg |
Sulfinpyrazone Sulfone |
1106-50-9 | 50mg |
$133.00 | 2023-05-17 | ||
| TRC | S373690-250mg |
Sulfinpyrazone Sulfone |
1106-50-9 | 250mg |
$563.00 | 2023-05-17 | ||
| TRC | S373690-500mg |
Sulfinpyrazone Sulfone |
1106-50-9 | 500mg |
$ 800.00 | 2023-09-06 |
Sulfinpyrazone Sulfone Related Literature
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
-
Jason Wan Lab Chip, 2020,20, 4528-4538
Additional information on Sulfinpyrazone Sulfone
Comprehensive Overview of Sulfinpyrazone Sulfone (CAS No. 1106-50-9): Properties, Applications, and Research Insights
Sulfinpyrazone Sulfone (CAS No. 1106-50-9) is a chemically significant metabolite derived from Sulfinpyrazone, a compound initially developed for its uricosuric and antiplatelet properties. This article delves into the molecular characteristics, pharmacological relevance, and contemporary research trends surrounding Sulfinpyrazone Sulfone, addressing common queries such as "What is Sulfinpyrazone Sulfone used for?" and "How does Sulfinpyrazone Sulfone differ from its parent compound?".
The chemical structure of Sulfinpyrazone Sulfone features a sulfonyl group, which enhances its stability and metabolic profile compared to Sulfinpyrazone. Researchers have explored its potential in modulating oxidative stress pathways, a topic gaining traction due to rising interest in "antioxidant therapies" and "metabolic intermediates in drug development". Its CAS No. 1106-50-9 is frequently searched in academic databases, reflecting its niche yet impactful role in medicinal chemistry.
In pharmaceutical contexts, Sulfinpyrazone Sulfone is studied for its pharmacokinetic behavior, particularly its excretion dynamics and interactions with renal transporters. This aligns with trending searches like "kidney-friendly drug metabolites" and "drug safety profiling". Unlike its parent compound, Sulfinpyrazone Sulfone exhibits reduced platelet aggregation inhibition, making it a subject of debate in cardiovascular research forums.
Analytical methods for detecting Sulfinpyrazone Sulfone (CAS No. 1106-50-9) often employ HPLC or LC-MS, techniques frequently queried as "best practices for sulfone detection". Its synthesis involves oxidation of Sulfinpyrazone, a process scrutinized for yield optimization—a hot topic in "green chemistry" circles. The compound’s solubility in polar solvents also makes it a candidate for "aqueous formulation studies".
Emerging studies suggest Sulfinpyrazone Sulfone may influence inflammatory markers, sparking interest in queries like "Sulfinpyrazone Sulfone and inflammation". However, its clinical applications remain limited compared to Sulfinpyrazone, underscoring the need for further research—a gap often highlighted in "underutilized pharmaceutical metabolites" discussions. Patent databases reveal niche uses in specialized formulations, catering to searches such as "novel excipients".
From a regulatory standpoint, Sulfinpyrazone Sulfone (CAS No. 1106-50-9) is not classified as hazardous, aligning with "safe handling of drug metabolites" guidelines. Its environmental persistence is minimal, addressing concerns around "pharmaceutical pollution". Storage recommendations typically emphasize room-temperature stability, a detail often sought in "chemical storage protocols".
In summary, Sulfinpyrazone Sulfone represents a compelling case study in metabolite research, bridging gaps between "drug metabolism" and "therapeutic optimization". While its standalone applications are evolving, its role in understanding Sulfinpyrazone’s mechanism remains invaluable. Future studies may unlock its potential in niche therapeutic areas, reinforcing its relevance in modern pharmacology.
1106-50-9 (Sulfinpyrazone Sulfone) Related Products
- 57-96-5(Sulfinpyrazone)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)